The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot

STOCKHOLM, Jan. 3, 2025 /PRNewswire/ — SciBase Holding AB (“SciBase”) (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that it is working with Mayo Clinic, the leading US based hospital, on pigmented lesion digital workflows…